Abstract
In the nucleus of the cell, core RNA polymerase II (pol II) is associated with a large complex called the pol II holoenzyme (holo-pol)1,2. Transcription by core pol II in vitro on nucleosomal templates is repressed compared with that on templates of histone-free naked DNA3,4,5. We found that the transcriptional activity of holo-pol, in contrast to that of core pol II, is not markedly repressed on chromatin templates. We refer to this property of holo-pol as chromatin-dependent coactivation (CDC). Here we show that DNA topoisomerase IIα is associated with the holo-pol and is a required component of CDC. Etoposide and ICRF-193, specific inhibitors of topoisomerase II, blocked transcription on chromatin templates, but did not affect transcription on naked templates. Addition of purified topoisomerase IIα reconstituted CDC activity in reactions with core pol II. These findings suggest that transcription on chromatin templates results in the accumulation of superhelical tension, making the relaxation activity of topoisomerase II essential for productive RNA synthesis on nucleosomal DNA.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kim, Y. J., Bjorklund, S., Li, Y., Sayre, M. H. & Kornberg, R. D. A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II. Cell 77, 599–608 (1994).
Koleske, A. J. & Young, R. A. An RNA polymerase II holoenzyme responsive to activators. Nature 368, 466–469 (1994).
Laybourn, P. J. & Kadonaga, J. T. Role of nucleosomal cores and histone H1 in regulation of transcription by RNA polymerase II. Science 254, 238–245 (1991).
LeRoy, G., Orphanides, G., Lane, W. S. & Reinberg, D. Requirement of RSF and FACT for transcription of chromatin templates in vitro. Science 282, 1900–1904 (1998).
Sandaltzopoulos, R., Blank, T. & Becker, P. B. Transcriptional repression by nucleosomes but not H1 in reconstituted preblastoderm Drosophila chromatin. EMBO J. 13, 373–379 (1994).
Cramer, P. et al. Architecture of RNA polymerase II and implications for the transcription mechanism. Science 288, 640–649 (2000).
Cho, H. et al. A human RNA polymerase II complex containing factors that modify chromatin structure. Mol. Cell. Biol. 18, 5355–5363 (1998).
Parvin, J. D. & Young, R. A. Regulatory targets in the RNA polymerase II holoenzyme. Curr. Opin. Genet. Dev. 8, 565–570 (1998).
Thompson, N. E., Aronson, D. B. & Burgess, R. R. Purification of eukaryotic RNA polymerase II by immunoaffinity chromatography: Elution of active enzyme with protein stabilizing agents from a polyol-responsive monoclonal antibody. J. Biol. Chem. 265, 7069–7077 (1990).
Neish, A. S., Anderson, S. F., Schlegel, B. P., Wei, W. & Parvin, J. D. Factors associated with the mammalian RNA polymerase II holoenzyme. Nucleic Acids Res. 26, 847–853 (1998).
Chao, D. M. et al. A mammalian SRB protein associated with an RNA polymerase II holoenzyme. Nature 380, 82–85 (1996).
Workman, J. L., Taylor, I. C., Kingston, R. E. & Roeder, R. G. Control of class II gene transcription during in vitro nucleosome assembly. Methods Cell Biol. 35, 419–447 (1991).
Cho, H., Maldonado, E. & Reinberg, D. Affinity purification of a human RNA polymerase II complex using monoclonal antibodies against transcription factor IIF. J. Biol. Chem. 272, 11495–11502 (1997).
Scully, R. et al. BRCA1 is a component of the RNA polymerase II holoenzyme. Proc. Natl Acad. Sci. USA 94, 5605–5610 (1997).
Ishida, R. et al. DNA topoisomerase II is the molecular target of bisdioxopiperazine derivatives ICRF-159 and ICRF-193 in Saccharomyces cerevisiae. Cancer Res. 55, 2299–2303 (1995).
Liu, L. F. DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem. 58, 351–375 (1989).
Wang, J. C. & Lynch, A. S. Transcription and DNA supercoiling. Curr. Opin. Genet. Dev. 3, 764–768 (1993).
Gartenberg, M. R. & Wang, J. C. Positive supercoiling of DNA greatly diminishes mRNA synthesis in yeast. Proc. Natl Acad. Sci. USA 89, 11461–11465 (1992).
Schultz, M. C., Brill, S. J., Ju, Q., Sternglanz, R. & Reeder, R. H. Topoisomerases and yeast rRNA transcription: Negative supercoiling stimulates initiation and topoisomerase activity is required for elongation. Genes Dev. 6, 1332–1341 (1992).
Brill, S. J., DiNardo, S., Voelkel-Meiman, K. & Sternglanz, R. Need for DNA topoisomerase activity as a swivel for DNA replication for transcription of ribosomal RNA. Nature 326, 414–416 (1987); erratum Nature 326, 812 (1987).
Chasman, D. I., Leatherwood, J., Carey, M., Ptashne, M. & Kornberg, R. D. Activation of yeast polymerase II transcription by herpesvirus VP16 and GAL4 derivatives in vitro. Mol. Cell. Biol. 9, 4746–4749 (1989).
Manley, J. L., Fire, A., Samuels, M. & Sharp, P. A. In vitro transcription: Whole-cell extract. Methods Enzymol. 101, 568–582 (1983).
Haile, D. T. & Parvin, J. D. Activation of transcription in vitro by the BRCA1 carboxyl-terminal domain. J. Biol. Chem. 274, 2113–2117 (1999).
Chiang, C. M. & Roeder, R. G. Expression and purification of general transcription factors by FLAG epitope-tagging and peptide elution. Pept. Res. 6, 62–64 (1993).
Schlegel, B. P., Green, V. J., Ladias, J. A. & Parvin, J. D. BRCA1 interaction with RNA polymerase II reveals a role for hRPB2 and hRPB10α in activated transcription. Proc. Natl Acad. Sci. USA 97, 3148–3153 (2000).
Acknowledgements
We thank A. Dutta, J. Wohlschlagel, Z. Jonsson and S. K. Dhar for encouragement and advice throughout the course of this study; U. Banerjee, M. Kannapiran and W. Wei for preparation of extracts; and J. C. Wang for the gift of ICRF-193. This work was supported by a grant from the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Figure S1
(JPG 19.9 KB)
Micrococcal nuclease digestion of chromatin templates. Naked DNA templates and different chromatin preparations were tested for sensitivity to digestion by micrococcal nuclease. Naked DNA (panel a) was completely digested by nuclease after 2 minutes in the presence of the enzyme, whereas chromatin templates without added topoisomerase (panel b) or with topoisomerase IIa (panel c) were resistant to extended treatment (15 min) with the nuclease. In each set of reactions, the template was incubated with micrococcal nuclease at 37℃ for 0 min (lanes 1, 5), 2 min (lanes 2, 6), 5 min (lanes 3, 7) or 15 min (lanes 4, 8).
Figure S2
(JPG 7.23 KB)
Assessment of the purity of topoisomerase preparation. DNA topoisomerase IIa was subjected to SDS-PAGE and stained with silver. The topoisomerase IIa preparation contains a single polypeptide migrating at 170 kd, consistent with its known molecular mass.
Rights and permissions
About this article
Cite this article
Mondal, N., Parvin, J. DNA topoisomerase IIα is required for RNA polymerase II transcription on chromatin templates. Nature 413, 435–438 (2001). https://doi.org/10.1038/35096590
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/35096590
This article is cited by
-
Release of paused RNA polymerase II at specific loci favors DNA double-strand-break formation and promotes cancer translocations
Nature Genetics (2019)
-
Increasing the distance between two monomers of topoisomerase IIβ under the action of antitumor agent 4β-sulfur-(benzimidazole) 4′-demethylepipodophyllotoxin
Scientific Reports (2018)
-
Post-translational modifications in DNA topoisomerase 2α highlight the role of a eukaryote-specific residue in the ATPase domain
Scientific Reports (2018)
-
Topoisomerases and the regulation of neural function
Nature Reviews Neuroscience (2016)
-
Topoisomerase IIα promotes activation of RNA polymerase I transcription by facilitating pre-initiation complex formation
Nature Communications (2013)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.